Symbol="XERS"
AssetType="Common Stock"
Name="Xeris Pharmaceuticals Inc"
Description="Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets ready-to-use injectable and infusible drug formulations. The company is headquartered in Chicago, Illinois."
CIK="1867096"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="180 N. LASALLE STREET, SUITE 1600, CHICAGO, IL, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="313069000"
EBITDA="-42287000"
PERatio="None"
PEGRatio="None"
BookValue="0.099"
DividendPerShare="0"
DividendYield="0"
EPS="-0.54"
RevenuePerShareTTM="0.981"
ProfitMargin="-0.533"
OperatingMarginTTM="-0.407"
ReturnOnAssetsTTM="-0.105"
ReturnOnEquityTTM="-1.631"
RevenueTTM="134073000"
GrossProfitTTM="87614000"
DilutedEPSTTM="-0.54"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.502"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.849"
PriceToBookRatio="3.409"
EVToRevenue="2.362"
EVToEBITDA="-2.101"
Beta="1.81"
num_52WeekHigh="3.07"
num_52WeekLow="0.97"
num_50DayMovingAverage="2.62"
num_200DayMovingAverage="1.873"
SharesOutstanding="137311000"
DividendDate="None"
ExDividendDate="None"
symbol="XERS"
open="2.34"
high="2.41"
low="2.25"
price="2.28"
volume="931188.00"
latest_trading_day="2023-08-11"
previous_close="2.33"
change="-0.05"
change_percent="-2.1459%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="7"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="93"
Volume_recent_avg="1219417"
Change_recent_avg="0.01"
Delta_recent_avg="0.16"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="0.35"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="93"
Aroon_momentum_negative="7"
image_negative_thumbnail_id_1="1088"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0121.jpeg"
image_negative_thumbnail_id_2="488"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0117.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="554"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_positive_thumbnail_id_1="980"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0142.jpeg"
image_positive_thumbnail_id_2="683"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0025.jpeg"
image_professor_thumbnail_id_1="1183"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
